Skip to content

Gut Microbiome and Colorectal Cancer

Gut Microbiome Dyspiosis in Colorectal Cancer Egyptian Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06748339
Enrollment
18
Registered
2024-12-27
Start date
2024-01-01
Completion date
2024-12-17
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

CRC, microbiome

Brief summary

Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries. It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle. In Egypt, CRC represents the seventh most common cancer. It is the third most reported cancer in males and the fifth most common cancer in females. microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target

Detailed description

Many reports suggested the role of westernized dietary lifestyles, including high consumption of red meats, animal fats, and cholesterol-rich foods, as well as smoking, decreased physical activity, obesity, diabetes, alcohol consumption, or smoking, in CRC development. These changes in lifestyle are called the external factors, which are now linked to changes in the inner gut microenvironments, mainly the microbiomes. Our aim is to investigate the the changes in microbiome profile in relation to clinical, pathological and lifestyle factors

Interventions

OTHERno intervention

no intervention

Sponsors

Heliopolis University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of 40 years to 80 years * Patients with a newly diagnosed CRC

Exclusion criteria

* Patients with previously known CRC * Pregnancy or Lactation * Abdominal surgery within/up to 6 months prior to sample collection * Antibiotics, corticosteroids, or probiotics up to three months prior to sample collection * History of other types of cancer * Subjects on a special diet * Diabetes, liver, or kidney diseases * CRC patients who used enema or underwent colonoscopy up to one week before sample collection.

Design outcomes

Primary

MeasureTime frameDescription
The effect of food and lifestyle on microbiomethrough study completion, an average of 1 yearcorrelation between food and lifestyle with microbiome profiles
microbiome profile and CRC pathogensisthrough study completion, an average of 1 yearcorrelation between microbiome profile and CRC pathogensis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026